Documenti analoghi

• Erythropoietin hyporesponsiveness in non‐alcoholic fatty liver disease
  di: Huixi Zou, et al.
  Pubblicazione: (2024)
• Prevalence and predictors of non‐alcoholic fatty liver disease (NAFLD) and metabolic dysfunction‐associated fatty liver disease (MAFLD) in Indian women with polycystic ovarian syndrome
  di: Aditi Rathi, et al.
  Pubblicazione: (2025)
• Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
  di: Yu‐Ming Cheng, et al.
  Pubblicazione: (2024)
• Letter to “Prevalence and predictors of non‐alcoholic fatty liver disease ( NAFLD ) and metabolic dysfunction‐associated fatty liver disease ( MAFLD ) in Indian women with polycystic ovarian syndrome”
  di: Francis de Zegher, et al.
  Pubblicazione: (2025)
• Hepatoprotective effects and mechanisms of l‐theanine and epigallocatechin gallate combined intervention in alcoholic fatty liver rats
  di: Kai‐Hang Xu, et al.
  Pubblicazione: (2024)